Diampa MXR 12.5/1000mg Tablet – Empagliflozin 12.5mg + Metformin XR 1000mg Extended-Release Dual Therapy
Diampa MXR 12.5/1000mg Tablet – Empagliflozin 12.5mg + Metformin XR 1000mg Extended-Release Dual Therapy
Diampa MXR 12.5/1000mg Tablet – Empagliflozin 12.5mg + Metformin XR 1000mg Extended-Release Dual Therapy
Description
Diampa MXR 12.5/1000mg Tablet – All-Day Glucose Control with Extended-Release Convenience
Diampa MXR 12.5/1000mg Tablet is an innovative extended-release formulation that combines Empagliflozin 12.5mg (SGLT2 inhibitor) with Metformin XR 1000mg in a single once-daily tablet. The extended-release technology delivers metformin gradually over 24 hours, dramatically reducing stomach side effects while Empagliflozin continues to eliminate excess glucose through urine. This smart combination offers powerful HbA1c reduction, proven cardiovascular & kidney protection, meaningful weight loss, and the ease of true once-daily dosing – perfect for patients who struggle with twice-daily tablets or experience GI intolerance with immediate-release metformin.
